0001209191-12-041067.txt : 20120809 0001209191-12-041067.hdr.sgml : 20120809 20120809133440 ACCESSION NUMBER: 0001209191-12-041067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120808 FILED AS OF DATE: 20120809 DATE AS OF CHANGE: 20120809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 121019655 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2012-08-08 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2012-08-08 4 M 0 4000 15.60 A 636895 D Common Stock 2012-08-08 4 S 0 2200 50.78 D 634695 D Common Stock 2012-08-08 4 S 0 1800 51.26 D 632895 D Common Stock 13286 I 401(k) Common Stock 300000 I Common Stock held in trust. Employee Stock Option (right to buy) 15.60 2012-08-08 4 M 0 4000 0.00 D 2013-01-17 Common Stock 4000 82951 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $50.78 (range $50.48 to $50.99). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $51.26 (range $51.07 to $51.89). Common stock held in grantor retained annuity trusts. Fully vested. Valerie L. Andrews, Attorney-In-Fact 2012-08-09